BioSpace News Archive

Emerald Health Pharmaceuticals Inc. (EHP or the Company), a clinical-stage biotechnology company developing a new class of medicines to treat diseases with unmet medical needs, has expanded its Scientific Advisory Board with the appointment of neuroscience expert and innovator, Eduardo Candelario-Jalil, PhD.

Certara, Inc., a global leader in biosimulation, announced that it will release financial results for the second quarter of 2021 after the market close on Thursday, August 5, 2021.

Taro Pharmaceutical Industries Ltd. announced that it has accepted the resignation of its Chief Financial Officer, Daphne Huang, effective August 6, 2021.

Injectable usually refers to a drug delivery system and acts as an alternative to oral drugs.

The laboratory balances and scales market is expected to reach US$ 2,131.14 million in 2028 from US$ 1,463.53 million in 2021. The market is estimated to grow with a CAGR of 5.5% from 2021-2028.

The global preterm birth control market is expected to reach US$ 1,809.0 Mn in 2025 from US$ 1,190.5 in 2017. The market is estimated to grow with a CAGR of 4.9% from 2018-2025.

The Venous stents market was valued at US$ 829.0 million in 2017 and it is projected to reach US$ 1,727.4 million by 2025; it is expected to grow at a CAGR of 9.7% from 2018 to 2025.

Emerald Health Pharmaceuticals Inc. (EHP or the Company), a clinical-stage biotechnology company developing a new class of medicines to treat neurodegenerative, autoimmune and other diseases with unmet medical needs, has initiated activities for a Phase 2 international clinical study for the treatment of patients with multiple sclerosis (MS).

Kintor Pharmaceutical Limited (HKEX:9939) today announced that it has entered into a licensing agreement with Shanghai Fosun Pharmaceutical Development Ltd. (“Fosun Pharma Development”), on the commercialisation of proxalutamide for the treatment of COVID-19 indication in India and 28 African countries (the"Collaboration Regions”).

The COVID-19 pandemic continues to create stress and anxiety for many Canadians, particularly those who do not have ready access to their regular support networks.